Page last updated: 2024-08-23

3,3',5,5'-tetramethylbenzidine and EHS Tumor

3,3',5,5'-tetramethylbenzidine has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Filimonov, A; Filimonova, M; Ivanov, S; Kaprin, A; Koryakin, S; Makarchuk, V; Saburov, V; Saburova, A; Sevankaeva, L; Shegay, P; Shevchenko, L; Surinova, V; Yakovleva, N; Yuzhakov, V1

Other Studies

1 other study(ies) available for 3,3',5,5'-tetramethylbenzidine and EHS Tumor

ArticleYear
The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues.
    International journal of molecular sciences, 2021, Aug-28, Volume: 22, Issue:17

    Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Gamma Rays; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Radiation Protection; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Thiourea

2021